Skip to content
Trial Eligibility
Menu

Objective Assessment of Outcomes Following Immediate Lymphatic Reconstruction / LYMPHA

NCT06650592

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Immediate lymphatic reconstruction (ILR) is a novel surgical approach performed at the time of initial lymph node dissection with the goal of preventing lymphedema. It involves the identification of lymphatic channels that are transected after lymph node dissection and microsurgical anastomosis of one or more lymphatic channel with a local recipient vein to re-direct upper extremity lymphatic drainage.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Lymphatic Reconstruction

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
Any age
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Chicago
Last updated on ClinicalTrials.gov
February 2, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • The University o Chicago · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.